Howe & Rusling Inc Magenta Therapeutics, Inc. Transaction History

Howe & Rusling Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.97 - $3.08 $61 - $194	-63 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$2.55 - $5.23 $68 - $141	-27 Reduced 30.0%	63 $0
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $182 - $296	30 Added 50.0%	90 $1,000
Q2 2021 Aug 13, 2021	BUY	$9.76 - $14.15 $585 - $849	60 New	60 $1,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.